169 related articles for article (PubMed ID: 36169546)
1. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
[No Abstract] [Full Text] [Related]
2. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
3. New MRI features improve subtype classification of hepatocellular adenoma.
Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
[TBL] [Abstract][Full Text] [Related]
4. Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping.
Reizine E; Ronot M; Pigneur F; Purcell Y; Mulé S; Dioguardi Burgio M; Calderaro J; Amaddeo G; Laurent A; Vilgrain V; Luciani A
Eur Radiol; 2019 Jul; 29(7):3791-3801. PubMed ID: 30937584
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
Kim TH; Woo S; Ebrahimzadeh S; McInnes MDF; Gerst SR; Do RK
AJR Am J Roentgenol; 2023 Jan; 220(1):28-38. PubMed ID: 35920706
[No Abstract] [Full Text] [Related]
6. Hepatocellular adenoma subtyping by qualitative MRI features and machine learning algorithm of integrated qualitative and quantitative features: a proof-of-concept study.
Liu X; Espin-Garcia O; Khalvati F; Namdar K; Fischer S; Haider MA; Jhaveri KS
Clin Radiol; 2023 Sep; 78(9):679-686. PubMed ID: 37365116
[TBL] [Abstract][Full Text] [Related]
7. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
Tse JR; Naini BV; Lu DS; Raman SS
Radiology; 2016 Apr; 279(1):118-27. PubMed ID: 26505921
[TBL] [Abstract][Full Text] [Related]
9. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
[TBL] [Abstract][Full Text] [Related]
10. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience.
Garcovich M; Faccia M; Meloni F; Bertolini E; de Sio I; Calabria G; Francica G; Vidili G; Riccardi L; Zocco MA; Ainora ME; Ponziani FR; De Gaetano AM; Gasbarrini A; Rapaccini GL; Pompili M
J Ultrasound; 2019 Jun; 22(2):157-165. PubMed ID: 30306412
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
[TBL] [Abstract][Full Text] [Related]
13. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
[TBL] [Abstract][Full Text] [Related]
15. Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings.
Laumonier H; Cailliez H; Balabaud C; Possenti L; Zucman-Rossi J; Bioulac-Sage P; Trillaud H
AJR Am J Roentgenol; 2012 Aug; 199(2):341-8. PubMed ID: 22826395
[TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype correlations in hepatocellular adenoma: an update of MRI findings.
Thomeer MG; E Bröker ME; de Lussanet Q; Biermann K; Dwarkasing RS; de Man R; Ijzermans JN; de Vries M
Diagn Interv Radiol; 2014; 20(3):193-9. PubMed ID: 24509184
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of MRI features of hepatocyte nuclear factor 1α-inactivated hepatocellular adenoma].
Pan H; Chen XF; Han J; Ji Y; Zeng MS; Wang ML
Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1192-1197. PubMed ID: 38238954
[No Abstract] [Full Text] [Related]
20. Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens.
Bioulac-Sage P; Taouji S; Le Bail B; Possenti L; Balabaud C
Int J Hepatol; 2013; 2013():417323. PubMed ID: 23509631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
